pDONR223-PAK2 Citations (3)

Originally described in: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Johannessen CM, Boehm JS, Kim SY, Thomas SR, Wardwell L, Johnson LA, Emery CM, Stransky N, Cogdill AP, Barretina J, Caponigro G, Hieronymus H, Murray RR, Salehi-Ashtiani K, Hill DE, Vidal M, Zhao JJ, Yang X, Alkan O, Kim S, Harris JL, Wilson CJ, Myer VE, Finan PM, Root DE, Roberts TM, Golub T, Flaherty KT, Dummer R, Weber BL, Sellers WR, Schlegel R, Wargo JA, Hahn WC, Garraway LA Nature. 2010 Dec 16;468(7326):968-72. doi: 10.1038/nature09627 PubMed Journal

---

Articles Citing pDONR223-PAK2

Articles
p21-activated kinase 2 regulates HSPC cytoskeleton, migration, and homing via CDC42 activation and interaction with beta-Pix. Reddy PN, Radu M, Xu K, Wood J, Harris CE, Chernoff J, Williams DA. Blood. 2016 Apr 21;127(16):1967-75. doi: 10.1182/blood-2016-01-693572. Epub 2016 Mar 1. PubMed
Lyso-PAF, a biologically inactive phospholipid, contributes to RAF1 activation. Gao X, Liu Y, Li Y, Fan H, Wu R, Zhang R, Faubert B, He YY, Bissonnette MB, Xia S, Chen D, Mao H, Boggon TJ, Chen J. Mol Cell. 2022 Jun 2;82(11):1992-2005.e9. doi: 10.1016/j.molcel.2022.03.026. Epub 2022 Apr 12. PubMed
A role for class I p21-activated kinases in the regulation of the excitability of the actin cytoskeleton. Tyler JJ, Davidson A, Poxon ME, Llanses Martinez M, Hume P, King JS, Koronakis V. J Cell Sci. 2025 Jun 15;138(12):jcs263763. doi: 10.1242/jcs.263763. Epub 2025 Jun 23. PubMed

If you have published an article using this material, please email us at to have your article added to this page.